Table 2.
Group | GS 0 | GS 1 Lesion | GS 1 Non-lesion | GS 2 Lesion | GS 2 Non-lesion | Treated Lesion | Treated Non-lesion |
---|---|---|---|---|---|---|---|
Predicted GS | 0.14 ± 0.078 | 1.03 ± 0.419 | −0.01 ± 0.089 | 2.09 ± 0.519 | 0.03 ± 0.102 | −0.19 ± 0.029 | 0.05 ± 0.061 |
The model was constructed using the expression values of the genes that contributed most to the variability observed in components 1 and 2 of the PCA analyses shown in Figs 5 and 6 (muc5, muc18, muc2, il4/13a, il4/13b2 and tnfα3) as X variables, and gill score (GS) as Y variable. The in vivo challenge dataset served as the training set. Values show the mean (±SEM) predicted GS of the different field experiment sample groups.